Evidence map›Paper›PMID 40386571›Full record

ArticleArXiv2025

Modeling the 2022 Mpox Outbreak with a Mechanistic Network Model.

Emma G Crenshaw, Jukka-Pekka Onnela

Abstract readPreprint
In one paragraph

Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Emma G CrenshawDepartment of Biostatistics, Harvard TH Chan School of Public Health, 677 Huntington Avenue, Boston, 02115, MA, USA.
Jukka-Pekka OnnelaDepartment of Biostatistics, Harvard TH Chan School of Public Health, 677 Huntington Avenue, Boston, 02115, MA, USA.

Funding

BIOSTATISTICS/EPIDEMIOLOGY TRAINING GRANTS IN AIDST32AI007358 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Michael David Hughes · 1989 to 2026
$12.4M
Bridging Statistical Inference and Mechanistic Network Models for HIV/AIDSR01AI138901 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Ravi Goyal, Jukka-Pekka Onnela · 2019 to 2026
$3.4M
NIAID NIH HHS R01 AI138901NIAID NIH HHS T32 AI007358
6 · The paper itself

Abstract

Background: The 2022 outbreak of mpox affected more than 80,000 individuals worldwide, most of whom were men who have sex with men (MSM) who likely contracted the disease through close contact during sex. Given the unprecedented number of mpox infections and the new route of infection, there was substantial uncertainty about how best to manage the outbreak. Methods: We implemented a dynamic agent-based network model to simulate the spread of mpox in a United States-based MSM population. This model allowed us to implement data-informed dynamic network evolution to simulate realistic disease spreading and behavioral adaptations. Results: We found that behavior change, the reduction in one-time partnerships, and widespread vaccination are effective in preventing the transmission of mpox and that earlier intervention has a greater effect, even when only a high-risk portion of the population participates. With no intervention, 16% of the population was infected (25th percentile, 75th percentiles of simulations: 15.3%, 16.6%). With vaccination and behavior change in only the 25% of individuals most likely to have a one-time partner, cumulative infections were reduced by 30%, or a total reduction in nearly 500 infections (mean: 11.3%, Conclusion: With the ability to model individuals' behavior, mechanistic networks are particularly well suited to studying sexually transmitted infections, the spread and control of which are often governed by individual-level action. Our results contribute valuable insights into the role of different interventions and relationship types in mpox transmission dynamics.

Indexed as

MpoxMSMnetwork modelingsimulation

Identifiers

PMID40386571
PMCPMC12083702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.